David Carmody

2.3k total citations
46 papers, 936 citations indexed

About

David Carmody is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Genetics. According to data from OpenAlex, David Carmody has authored 46 papers receiving a total of 936 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Surgery, 25 papers in Endocrinology, Diabetes and Metabolism and 13 papers in Genetics. Recurrent topics in David Carmody's work include Pancreatic function and diabetes (21 papers), Diabetes Management and Research (11 papers) and Diabetes and associated disorders (8 papers). David Carmody is often cited by papers focused on Pancreatic function and diabetes (21 papers), Diabetes Management and Research (11 papers) and Diabetes and associated disorders (8 papers). David Carmody collaborates with scholars based in United States, Singapore and Australia. David Carmody's co-authors include Siri Atma W. Greeley, Louis H. Philipson, Rochelle N. Naylor, Graeme I. Bell, Priya M. John, Gorka Alkorta‐Aranburu, Aaron N. Winn, Jessica Hwang, Elbert S. Huang and Daniela del Gaudio and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

David Carmody

41 papers receiving 894 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Carmody United States 18 531 388 367 198 159 46 936
Itai Gans United States 16 832 1.6× 179 0.5× 178 0.5× 88 0.4× 43 0.3× 28 1.0k
Claudia Giavoli Italy 23 285 0.5× 236 0.6× 1.1k 2.9× 189 1.0× 173 1.1× 85 1.5k
Denise Engelbrecht Zantut‐Wittmann Brazil 20 243 0.5× 92 0.2× 764 2.1× 96 0.5× 47 0.3× 81 1.1k
Alexander Taylor United States 14 241 0.5× 62 0.2× 111 0.3× 108 0.5× 126 0.8× 32 1.0k
Wai‐Wang Chau Hong Kong 19 846 1.6× 140 0.4× 33 0.1× 77 0.4× 113 0.7× 84 1.2k
M Guftar Shaikh United Kingdom 15 94 0.2× 248 0.6× 331 0.9× 369 1.9× 213 1.3× 57 954
M Vanelli Italy 14 281 0.5× 498 1.3× 558 1.5× 117 0.6× 161 1.0× 43 1.1k
Francesco Cadario Italy 17 341 0.6× 368 0.9× 379 1.0× 142 0.7× 107 0.7× 32 978
Mario Skugor United States 14 118 0.2× 93 0.2× 336 0.9× 95 0.5× 231 1.5× 22 1.0k
Gülay Karagüzel Türkiye 14 122 0.2× 153 0.4× 193 0.5× 180 0.9× 70 0.4× 58 697

Countries citing papers authored by David Carmody

Since Specialization
Citations

This map shows the geographic impact of David Carmody's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Carmody with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Carmody more than expected).

Fields of papers citing papers by David Carmody

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Carmody. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Carmody. The network helps show where David Carmody may publish in the future.

Co-authorship network of co-authors of David Carmody

This figure shows the co-authorship network connecting the top 25 collaborators of David Carmody. A scholar is included among the top collaborators of David Carmody based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Carmody. David Carmody is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Wang, Zifei, Zhiwen Joseph Lo, Enming Yong, et al.. (2025). Creation of a National Chronic Wound Registry—Challenges and Opportunities. International Wound Journal. 22(3). e70146–e70146. 1 indexed citations
3.
Lo, Zhiwen Joseph, Enming Yong, Tze Tec Chong, et al.. (2025). A Multi‐Center Prospective Study on the Healing of Neuro‐Ischemic Ulcers in Singapore: A Prospective Cohort Study. Health Science Reports. 8(1). e70332–e70332.
4.
Yoon, Sungwon, Hendra Goh, Phong Ching Lee, et al.. (2024). Assessing the Utility, Impact, and Adoption Challenges of an Artificial Intelligence–Enabled Prescription Advisory Tool for Type 2 Diabetes Management: Qualitative Study. JMIR Human Factors. 11. e50939–e50939. 4 indexed citations
5.
Bee, Yong Mong, et al.. (2024). A drug mix and dose decision algorithm for individualized type 2 diabetes management. npj Digital Medicine. 7(1). 254–254. 1 indexed citations
6.
Lewis, Thomas, et al.. (2024). Clinical outcomes of subtalar arthroereisis for the treatment of stage 1 flexible progressive collapsing foot deformity. European Journal of Orthopaedic Surgery & Traumatology. 34(6). 2933–2940. 1 indexed citations
7.
Chan, Kai Siang, Zhiwen Joseph Lo, Zifei Wang, et al.. (2023). A prospective study on the wound healing and quality of life outcomes of patients with venous leg ulcers in Singapore—Interim analysis at 6 month follow up. International Wound Journal. 20(7). 2608–2617. 6 indexed citations
8.
Graves, Nicholas, Ganga Ganesan, Kelvin Bryan Tan, et al.. (2023). Chronic wounds in a multiethnic Asian population: a cost of illness study. BMJ Open. 13(9). e065692–e065692. 8 indexed citations
9.
Carmody, David, Lucy J. Salmon, Leo A. Pinczewski, et al.. (2022). Foot Pain is Common, But Frequently Improves 1 Year After Total Knee Arthroplasty. The Journal of Arthroplasty. 37(6). 1069–1073. 1 indexed citations
10.
11.
Kwan, Yu Heng, et al.. (2020). A collaborative approach in patient education for diabetes foot and wound care: A pragmatic randomised controlled trial. International Wound Journal. 17(6). 1678–1686. 15 indexed citations
12.
Sy, Park, May Sanyoura, David Carmody, et al.. (2018). FOXP3 mutations causing early-onset insulin-requiring diabetes but without other features of immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome. Yearbook of pediatric endocrinology. 5 indexed citations
13.
Carmody, David. (2017). Monogenic Diabetes: Gene directed therapy and mutation specific phenotypes. Figshare. 1 indexed citations
14.
Hwang, Jessica, Soo Young Park, Honggang Ye, et al.. (2017). FOXP3 mutations causing early‐onset insulin‐requiring diabetes but without other features of immune dysregulation, polyendocrinopathy, enteropathy, X‐linked syndrome. Pediatric Diabetes. 19(3). 388–392. 24 indexed citations
15.
Carmody, David, Rochelle N. Naylor, Charles D. Bell, et al.. (2016). GCK-MODY in the US National Monogenic Diabetes Registry: frequently misdiagnosed and unnecessarily treated. Acta Diabetologica. 53(5). 703–708. 57 indexed citations
16.
Alkorta‐Aranburu, Gorka, Madina Sukhanova, David Carmody, et al.. (2016). Improved molecular diagnosis of patients with neonatal diabetes using a combined next-generation sequencing and MS-MLPA approach. Journal of Pediatric Endocrinology and Metabolism. 29(5). 523–531. 16 indexed citations
17.
Carmody, David, et al.. (2015). Posterior tibial tendon dysfunction: An overlooked cause of foot deformity. SHILAP Revista de lepidopterología. 4(1). 26–26. 37 indexed citations
18.
Carmody, David, et al.. (2015). An online monogenic diabetes discussion group: supporting families and fueling new research. Translational research. 166(5). 425–431. 6 indexed citations
19.
Alkorta‐Aranburu, Gorka, David Carmody, Viswateja Nelakuditi, et al.. (2014). Phenotypic heterogeneity in monogenic diabetes: The clinical and diagnostic utility of a gene panel-based next-generation sequencing approach. Molecular Genetics and Metabolism. 113(4). 315–320. 65 indexed citations
20.
Carmody, David, et al.. (2009). Teenage pregnancy in type 1 diabetes mellitus. Pediatric Diabetes. 11(2). 111–115. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026